4-butyrolactone has been researched along with Endotoxemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, J; Huang, J; Jiang, R; Tang, L; Tian, R; Yang, Y; Zhang, L | 1 |
Bennett, T; Bycroft, BW; Chhabra, SR; Gardiner, SM; Harty, C; Pritchard, DI; Williams, P | 1 |
2 other study(ies) available for 4-butyrolactone and Endotoxemia
Article | Year |
---|---|
The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia.
Topics: 4-Butyrolactone; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Animals; Carbazoles; Carrier Proteins; Cell Cycle Proteins; Endotoxemia; Eukaryotic Initiation Factors; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Phosphoproteins; Phosphorylation; Plasminogen Activator Inhibitor 1; Sirtuin 1; Thromboplastin; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2017 |
Haemodynamic effects of the bacterial quorum sensing signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone, in conscious, normal and endotoxaemic rats.
Topics: 4-Butyrolactone; Animals; Antihypertensive Agents; Atenolol; Atrial Function; Atropine; Blood Pressure; Cardiovascular System; Consciousness; Dose-Response Relationship, Drug; Endotoxemia; Heart Atria; Heart Rate; Hemodynamics; Hindlimb; Homoserine; Kidney; Lipopolysaccharides; Male; Mesentery; Rats; Rats, Long-Evans; Regional Blood Flow; Structure-Activity Relationship | 2001 |